Literature DB >> 11896073

Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases.

H H J Backus1, C J Van Groeningen, W Vos, D F Dukers, E Bloemena, D Wouters, H M Pinedo, G J Peters.   

Abstract

AIMS: Tumour cell growth results from a disturbance in the balance between the rate of proliferation and cell death. In this study, proteins involved in the regulation of cell cycle arrest and apoptosis were studied as possible factors responsible for uncontrolled cell growth in colorectal cancer.
METHODS: The expression of proteins involved in these processes was investigated in 48 metastases from patients with colorectal cancer and compared with eight normal colon mucosa samples and 14 primary tumours. Both primary tumours and metastases were obtained from eight patients. The expression of thymidylate synthase (TS), p53, retinoblastoma protein (Rb), Fas receptor, Fas ligand, bcl-2, mcl-1, bax, and bcl-x was measured using immunohistochemistry. Proliferation was determined by Ki67 staining, whereas apoptosis was assessed by M30 immunostaining, which recognises cleaved cytokeratin 18.
RESULTS: In the limited number of cases in which paired comparisons were possible, the expression of TS and Ki67 was significantly higher in metastases than in the matched primary tumour samples (p = 0.014 and 0.016, respectively), whereas Rb expression was lower in metastases than in primary tumours (p = 0.024). Fas receptor expression was high in normal mucosa but absent in primary tumours and metastases, whereas the opposite was seen for p53. The expression of bax, mcl-1, and bcl-x in normal mucosa was more apical than that seen in malignant cells, where a more diffuse expression pattern was seen (p < 0.04). Apoptosis was more abundant in primary tumours than in metastases.
CONCLUSIONS: These results demonstrate that proliferation and apoptosis are disturbed during colorectal cancer progression, and this is accompanied by loss of Rb and Fas expression, the accumulation of p53 and TS, and changes in the expression patterns of bax, mcl-1, and bcl-xl.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896073      PMCID: PMC1769617          DOI: 10.1136/jcp.55.3.206

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  39 in total

1.  Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoclonal antibody.

Authors:  B Van Triest; B M Loftus; H M Pinedo; H H Backus; P Schoenmakers; F Telleman; T Tadema; G W Aherne; C J Van Groeningen; F A Zoetmulder; B G Taal; P G Johnston; G J Peters
Journal:  J Histochem Cytochem       Date:  2000-06       Impact factor: 2.479

Review 2.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

3.  5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients.

Authors:  H H Backus; D F Dukers; C J van Groeningen; W Vos; E Bloemena; D Wouters; J M van Riel; K Smid; G Giaccone; H M Pinedo; G J Peters
Journal:  Ann Oncol       Date:  2001-02       Impact factor: 32.976

4.  Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies.

Authors:  L Weiss; E Grundmann; J Torhorst; F Hartveit; I Moberg; M Eder; C M Fenoglio-Preiser; J Napier; C H Horne; M J Lopez
Journal:  J Pathol       Date:  1986-11       Impact factor: 7.996

Review 5.  Fluorouracil: biochemistry and pharmacology.

Authors:  H M Pinedo; G F Peters
Journal:  J Clin Oncol       Date:  1988-10       Impact factor: 44.544

6.  Balance of cell proliferation and apoptosis in breast carcinogenesis.

Authors:  E C Mommers; P J van Diest; A M Leonhart; C J Meijer; J P Baak
Journal:  Breast Cancer Res Treat       Date:  1999-11       Impact factor: 4.872

Review 7.  Where do we stand with 5-fluorouracil?

Authors:  H J Schmoll; T Büchele; A Grothey; W Dempke
Journal:  Semin Oncol       Date:  1999-12       Impact factor: 4.929

8.  Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays.

Authors:  M N Bobrow; T D Harris; K J Shaughnessy; G J Litt
Journal:  J Immunol Methods       Date:  1989-12-20       Impact factor: 2.303

9.  Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.

Authors: 
Journal:  J Clin Oncol       Date:  1992-06       Impact factor: 44.544

10.  Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.

Authors:  C P Spears; B G Gustavsson; M Berne; R Frösing; L Bernstein; A A Hayes
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

View more
  23 in total

1.  Tissue expression of the proteins fas and fas ligand in colorectal cancer and liver metastases.

Authors:  Stylianos Kykalos; Spuridon Mathaiou; Anastasios J Karayiannakis; Dimitris Patsouras; Maria Lambropoulou; Constantinos Simopoulos
Journal:  J Gastrointest Cancer       Date:  2012-06

2.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

3.  Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors.

Authors:  Ganepola A P Ganepola; Robert M Mazziotta; Dilendra Weeresinghe; Georgia A Corner; Cheryl J Parish; David H Chang; Niall C Tebbutt; Carmel Murone; Naseem Ahmed; Leonard H Augenlicht; John M Mariadason
Journal:  Clin Exp Metastasis       Date:  2009-11-01       Impact factor: 5.150

4.  Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.

Authors:  Kota V Ramana; Ravinder Tammali; Satish K Srivastava
Journal:  Mol Cancer Ther       Date:  2010-03-30       Impact factor: 6.261

5.  Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up.

Authors:  Silke Lassmann; Michael Hennig; Robert Rosenberg; Jörg Nährig; Joachim Schreglmann; Friedemann Krause; Manuela Poignee-Heger; Hjalmar Nekarda; Heinz Höfler; Martin Werner
Journal:  Int J Colorectal Dis       Date:  2005-08-13       Impact factor: 2.571

6.  A huge metastatic liver tumor from leiomyosarcoma of the inferior vena cava: report of a case.

Authors:  Masakazu Hashimoto; Tsuyoshi Kobayashi; Hirotaka Tashiro; Hironobu Amano; Akihiko Oshita; Yoshisato Tanimoto; Shintaro Kuroda; Hirofumi Tazawa; Hiroshi Aikata; Kazuaki Chayama; Masayoshi Fujii; Koji Arihiro; Hideki Ohdan
Journal:  Surg Today       Date:  2011-11-30       Impact factor: 2.549

7.  Correlation between Mcl-1 and pAKT protein expression in colorectal cancer.

Authors:  Evita B Henderson-Jackson; James Helm; Masoumeh Ghayouri; Ardeshir Hakam; Aejaz Nasir; Marino Leon; Marilyn Bui; Timothy Yeatman; Domenico Coppola
Journal:  Int J Clin Exp Pathol       Date:  2010-10-12

8.  Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery alone.

Authors:  Oliver Nehls; Holger G Hass; Thomas Okech; Silke Zenner; Chih-Jen Hsieh; Mario Sarbia; Franz Borchard; Hans-Helmut Gruenagel; Vera Gaco; Rainer Porschen; Michael Gregor; Bodo Klump
Journal:  Int J Colorectal Dis       Date:  2009-02-17       Impact factor: 2.571

9.  Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells.

Authors:  Henning Schulze-Bergkamen; Roland Ehrenberg; Lothar Hickmann; Binje Vick; Toni Urbanik; Christoph-C Schimanski; Martin-R Berger; Arno Schad; Achim Weber; Steffen Heeger; Peter-R Galle; Markus Moehler
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

10.  Can we improve the clinical risk score? The prognostic value of p53, Ki-67 and thymidylate synthase in patients undergoing radical resection of colorectal liver metastases.

Authors:  Arpad Ivanecz; Rajko Kavalar; Miroslav Palfy; Vid Pivec; Marko Sremec; Matjaž Horvat; Stojan Potrč
Journal:  HPB (Oxford)       Date:  2013-03-19       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.